MedPath

Study to find out whether patients with initial stage of mouth cancer do better if they undergo surgery followed by radiation compared to just undergoing surgery alone.

Not yet recruiting
Conditions
Radiation Therapy,
Registration Number
CTRI/2025/05/087040
Lead Sponsor
University of Oklahoma
Brief Summary

The purpose of this retrospective study is to investigate the difference in disease outcomes of patients who were treated with surgery plus adjuvant radiotherapy versus surgery alone for early-stage oral cavity squamous cell carcinoma (OC-SCC) with various risk factors. Currently, surgery is often used as the sole treatment modality of choice for patients with stage I and II OC-SCC. However, certain poor pathological features, such as higher worst pattern of invasion (WPOI), perineural invasion, and lymphovascular invasion, are associated with worse tumor biology and increase the risk of local recurrence, even in the early stages of oral cavity cancer. We seek to investigate whether patients with such high-risk features stand to gain benefit by receiving post-operative radiation therapy (PORT) in an effort to lower the risk of local recurrence, and potentially to improve overall survival. We also seek to learn more about patterns of spread, such as whether particular pathological features increase the chance of contralateral neck nodal failure

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
1500
Inclusion Criteria

Treated for early-stage (cT1-2N0M0) oral cavity cancer They must have been treated with curative intent via surgery, with or without adjuvant therapies Must have had at least two years of follow-up, or death.

Exclusion Criteria

Patients who are being treated for recurrence (either palliatively or by salvage surgery) or for distant metastasis at presentation.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall Survival between radiation and no radiation groups.3 year, 5 year
Overall Survival between radiation and no radiation groups in patients with WPOI V3 year, 5 year
Secondary Outcome Measures
NameTimeMethod
Recurrence rates between radiation & no radiation groups.Patterns of recurrence

Trial Locations

Locations (1)

Tata Memorial Hospital

🇮🇳

Mumbai, MAHARASHTRA, India

Tata Memorial Hospital
🇮🇳Mumbai, MAHARASHTRA, India
Dr Monali Swain
Principal investigator
9920739863
drmonaliswain@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.